TScan Therapeutics (TCRX) Stock: Buy, Sell, or Hold?
TCRX - TScan Therapeutics, Inc. Common Stock
$0.32
0.00 (0.94%)
▲
5d:
-5.74%
30d:
-15.9%
90d:
-69.48%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When TCRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TCRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TCRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TCRX is currently trading at $0.32, which is considered slightly low relative to its 30-day fair value range of $0.25 to $0.59.
Technical Outlook: Technically, TCRX is in a strong downtrend. The price is currently testing key support at $0.31. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TCRX scores 82/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.00 (+212.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TCRX is in a strong downtrend. The price is currently testing key support at $0.31. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TCRX scores 82/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.00 (+212.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.25 -
$0.59
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (82/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 212.0% below Wall St target ($1.00)
- CAUTION: Bottoming setup, but lagging the sector by 28% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-5.7%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.25 -
$0.59
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.31
Resistance Level
$0.37
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.56
Wall Street Target
$1.00
(+212.0%)
Revenue Growth (YoY)
-65.8%
Share & Embed Analysis
Last updated: October 03, 2026 4:28 AM ET
Data refreshes hourly during market hours. Next update: 5:28 AM
Data refreshes hourly during market hours. Next update: 5:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TCRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 54 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 48 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 67 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
